Table 1 Clinical characteristics according to baseline albuminuria group

Gender (% male)

50.5

65.0

66.7

No. of AER measurements^a

19 (8)

21 (8)

16 (8)

Duration of Follow-up (years)^a

8.5 (3.0)

8.7 (3.1)

6.5(2.8)

ACEi/ARB use (%)

51.9

77.6

80.4

Smoking (%)

48.9

55.6

54.9

Age (years)^b

66 (55, 73)

65 (58, 71)

64 (56, 69)

Diabetes duration (years)^b

9.80 (5.36, 17.26)

11.40 (6.22, 17.29)

13.00(8.077, 21.41)

SBP (mmHg)^a

139.4 (15.87)

142.39 (15.12)

143.58 (15.93)

BMI (kg/m²)^a

29.10 (26.15, 33.33)

30.28 (27.11, 34.68)

32.11 (28.43, 34.21)

HbA1c (%)^a

7.7 (1.4)

8.0 (1.4)

7.7 (1.8)

eGFR (ml/min/1.73m²)^a

74.6 (19.25)

70.69 (19.25)

55.01 (22.25)

Total cholesterol (mmol/L)^a

5.02 (0.99)

4.95 (0.92)

4.94 (1.13)

HDL-Cholesterol (mmol/L)^a

1.17 (0.96, 1.4)

1.09 (0.88, 1.29)

1.01 (0.88, 1.19)